Oppenheimer Cuts Integral Ad Science (NASDAQ:IAS) Price Target to $18.00

Integral Ad Science (NASDAQ:IAS) had its target price reduced by investment analysts at Oppenheimer from $20.00 to $18.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s price target indicates a potential upside of 59.15% from the company’s previous close.

A number of other research analysts also recently weighed in on the company. Raymond James raised their price objective on Integral Ad Science from $13.00 to $15.00 and gave the company an “outperform” rating in a research note on Friday, August 2nd. Benchmark reissued a “hold” rating on shares of Integral Ad Science in a research note on Monday, August 5th. Morgan Stanley raised their price objective on Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 23rd. Finally, Barclays lifted their price target on Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Monday, August 5th. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, Integral Ad Science has an average rating of “Moderate Buy” and a consensus price target of $16.20.

Integral Ad Science Stock Down 10.4 %

Shares of Integral Ad Science stock traded down $1.31 during trading on Wednesday, hitting $11.31. 234,076 shares of the stock traded hands, compared to its average volume of 1,383,232. The stock has a market cap of $1.83 billion, a P/E ratio of 1,132.13, a PEG ratio of 1.91 and a beta of 1.52. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.76 and a current ratio of 3.76. Integral Ad Science has a twelve month low of $7.98 and a twelve month high of $17.53. The company has a fifty day moving average price of $11.13 and a two-hundred day moving average price of $10.46.

Integral Ad Science (NASDAQ:IAS) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.02. Integral Ad Science had a return on equity of 0.31% and a net margin of 0.57%. The business had revenue of $133.50 million during the quarter, compared to analyst estimates of $138.06 million. During the same period in the previous year, the company earned ($0.09) EPS. The firm’s revenue was up 11.0% on a year-over-year basis. Equities research analysts predict that Integral Ad Science will post 0.23 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Tania Secor sold 5,240 shares of Integral Ad Science stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $52,976.40. Following the completion of the sale, the chief financial officer now directly owns 248,223 shares in the company, valued at $2,509,534.53. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CFO Tania Secor sold 5,240 shares of Integral Ad Science stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $52,976.40. Following the completion of the sale, the chief financial officer now directly owns 248,223 shares in the company, valued at $2,509,534.53. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Lisa Utzschneider sold 10,481 shares of the firm’s stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $105,962.91. Following the transaction, the chief executive officer now owns 239,709 shares in the company, valued at approximately $2,423,457.99. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 23,006 shares of company stock valued at $240,296. 2.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Integral Ad Science

Institutional investors have recently modified their holdings of the business. nVerses Capital LLC bought a new stake in Integral Ad Science in the 3rd quarter valued at approximately $45,000. Ameritas Investment Partners Inc. grew its holdings in Integral Ad Science by 40.1% in the 1st quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after buying an additional 1,924 shares in the last quarter. XTX Topco Ltd acquired a new position in Integral Ad Science in the 2nd quarter valued at $113,000. ProShare Advisors LLC acquired a new position in Integral Ad Science in the 1st quarter valued at $121,000. Finally, Edgestream Partners L.P. acquired a new position in Integral Ad Science in the 2nd quarter valued at $125,000. Institutional investors own 95.78% of the company’s stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.